Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 8/2007

01-08-2007 | Case Report

Successful coil embolization of a ruptured hepatic aneurysm in a patient with polyarteritis nodosa accompanied by angioimmunoblastic T cell lymphoma

Authors: Masahiro Nakashima, Kimihiro Suzuki, Makoto Okada, Kunio Takada, Hiroyuki Kobayashi, Yukihiro Hama

Published in: Clinical Rheumatology | Issue 8/2007

Login to get access

Abstract

Polyarteritis nodosa (PN) occasionally develops in association with malignant disorders. A 71-year-old man suddenly suffered from bleeding due to the rupture of a hepatic artery aneurysm. The ruptured lesion was embolized endovascularly by coiling, and the bleeding was stopped. A biopsy of the right inguinal lymph node demonstrated angioimmunoblastic T cell lymphoma (AITL). He received immunosuppressive treatment with transient response, although he relapsed 4 months later. To our knowledge, this is the first case of which PN was associated with AITL.
Literature
1.
Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192PubMedCrossRef
2.
Poveda F, Gonzalez-Garcia J, Picazo ML et al (1994) Systemic polyarteritis nodosa as the initial manifestation of a gastric adenocarcinoma. J Intern Med 236:679–683PubMedCrossRef
3.
Harris NL, Ferry JA (2001) Classification of Non-Hodgkin’s lymphomas. In: Knowles DM (ed) Neoplastic hematopathology. Lippincott Williams and Wilkins, Philadelphia, pp 691–753
4.
Lightfoot RW Jr, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093PubMedCrossRef
5.
Stone JH (2001) Vasculitides. In: Klippel JH, Crofford LJ, Stone JH, Weyand CM (eds) Primer on the rheumatic diseases. Arthritis Foundation, Atlanta, pp 385–414
6.
Stambo GW, Guiney MJ, Cannella XF, Germain BF (2004) Coil embolization of multiple hepatic artery aneurysms in a patient with undiagnosed polyarteritis nodosa. J Vasc Surg 39:1122–1124PubMedCrossRef
7.
Archimbaud E, Coiffier B, Bryon PA, Vasselon C, Brizard CP, Viala JJ (1987) Prognostic factors in angioimmunoblastic lymphadenopathy. Cancer 59:208–212PubMedCrossRef
8.
Frizzera G (2001) Atypical lymphoproliferative disorders. In: Knowles DM (ed) Neoplastic hematopathology. Lippincott Williams and Wilkins, Philadelphia, pp 569–622
9.
Fauci AS, Haynes B, Katz P (1978) The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 89:660–676PubMed
10.
Higuchi T, Mori H, Niikura H, Omine M (1996) Hypocomplementemia and hematological abnormalities in immunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T cell lymphoma. Acta Haematol 96:68–72PubMedCrossRef
Metadata
Title
Successful coil embolization of a ruptured hepatic aneurysm in a patient with polyarteritis nodosa accompanied by angioimmunoblastic T cell lymphoma
Authors
Masahiro Nakashima
Kimihiro Suzuki
Makoto Okada
Kunio Takada
Hiroyuki Kobayashi
Yukihiro Hama
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0383-2

Other articles of this Issue 8/2007

Clinical Rheumatology 8/2007 Go to the issue

Review Article

Burden and control of musculoskeletal conditions in developing countries: a joint WHO/ILAR/BJD meeting report

Original Article

Office capillaroscopy in systemic sclerosis

Original Article

Cross-cultural adaptation of the Behçet’s Disease Current Activity Form (BDCAF) to Brazilian Portuguese language

Original Article

Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation

Letter to the Editor

Surgery in rheumatoid arthritis patients under anti-TNF-α therapy: what is the risk?

Case Report

Cutaneous findings in patients with primary Sjogren’s syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits